Home Newsfeeds HC Wainwright & Co. Reiterates Neutral on Alkermes, Maintains $32 Price Target

HC Wainwright & Co. Reiterates Neutral on Alkermes, Maintains $32 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Alkermes (NASDAQ:ALKS) with a Neutral and maintains $32 price target.

byBenzinga Newsdesk

February 17, 2023

1 minute read

HC Wainwright & Co. analyst Douglas Tsao reiterates Alkermes (NASDAQ:ALKS) with a Neutral and maintains $32 price target.

Freshworks Cooks Up Strong 1Q23 Results, but Is the Recipe for Success Sustainable Amid Pricing Model Shifts?

By Anusuya Lahiri

May 3, 3:16 PM

Needham analyst Scott Berg reiterates Freshworks Inc (NASDAQ: FRSH) with a Buy and a $25

FRSH

Jerome Powell Will Testify Before Congress As Investors Await Fed’s Next Move On Inflation

By Wayne Duggan

March 6, 12:25 PM

The SPDR S&P 500 ETF Trust (NYSE: SPY) traded slightly higher Monday morning to kick off a big week for investors ahead of Federal Reserve Chair Jerome Powell's two-day testimony to Congress on Tuesday and Wednesday.

SPY

EXCLUSIVE: Plus Therapeutics Lead Candidate Shows Preliminary Safety, Efficacy In Type Of Brain Cancer

By Vandana Singh

August 11, 6:00 AM

Plus Therapeutics Inc (NASDAQ: PSTV) reported data from the ReSPECT-LM study evaluating the company’s lead radiotherapeutic, rhenium (186Re) obisbemeda, for

PSTV

Wipro Appoints Malay Joshi As Chief Executive Officer For Americas 1 Strategic Market Unit, Effective Immediately

By Benzinga Newsdesk

April 10, 10:10 AM

Wipro Limited (NYSE:WIT, BSE: 507685, NSE: WIPRO)))), a leading technology services and consulting company, announced today the appointment of Malay Joshi as Chief Executive Officer of Wipro Americas 1 Strategic Market

WIT

HC Wainwright & Co. Reiterates Neutral on Alkermes, Maintains $32 Price Target

Related Posts

Freshworks Cooks Up Strong 1Q23 Results, but Is the Recipe for Success Sustainable Amid Pricing Model Shifts?

Jerome Powell Will Testify Before Congress As Investors Await Fed’s Next Move On Inflation

EXCLUSIVE: Plus Therapeutics Lead Candidate Shows Preliminary Safety, Efficacy In Type Of Brain Cancer

Wipro Appoints Malay Joshi As Chief Executive Officer For Americas 1 Strategic Market Unit, Effective Immediately